Silencing of foxp3 enhances the antitumor efficacy of GM-CSf genetically modified tumor cell vaccine against B16 melanoma
- Miguel, A.
- Sendra, L.
- Noé, V.
- Ciudad, C.J.
- Dasí, F.
- Hervas, D.
- Herrero, M.J.
- Aliño, S.F.
Aldizkaria:
OncoTargets and Therapy
ISSN: 1178-6930
Argitalpen urtea: 2017
Alea: 10
Orrialdeak: 503-514
Mota: Artikulua
